Flubrotizolam is a potent a highly active benzodiazepine analogue. Introduced for clinical purposes, flubrotizolam possesses intense anxiolytic effects. Its pharmacological properties reveal a high affinity for the GABA receptor, leading to significant CNS modulation. Although its potential therapeutic applications, flubrotizolam's unregulated use